Abraham Ceesay Rapport Therapeutics, Inc. (RAPP) insider trading activity

RAPP Quotes by TradingView
Shares Held (Direct Ownership) 568K
2.99% 3M change
n/a 12M change
Total Value Held N/A

Abraham Ceesay Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Open market or private sale
$174,815 $29.97 p/Share
5,833 Reduced 1.02%
567,913 Common Stock
Nov 17 2025
SELL
Open market or private sale
$146,874 $25.18 p/Share
5,833 Reduced 1.01%
573,746 Common Stock
Oct 15 2025
SELL
Open market or private sale
$151,249 $25.93 p/Share
5,833 Reduced 1.0%
579,579 Common Stock
Sep 17 2025
SELL
Open market or private sale
$1,085,802 $26.59 p/Share
40,835 Reduced 6.52%
585,412 Common Stock

Also insider at

CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
President
PCRX
Pacira BioSciences, Inc. Healthcare
Director
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
AC

Abraham Ceesay

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on RAPP

Follow Rapport Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAPP shares.

Notify only if

Insider Trading

Get notified when an Rapport Therapeutics, Inc. insider buys or sells RAPP shares.

Notify only if

News

Receive news related to Rapport Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RAPP